The Zambia cholera vaccines market encompasses products such as Dukoral, Shanchol and Euvichol intended for active immunization against illness or disease caused by Vibrio cholera infection. Widespread outbreaks of cholera in Zambia have boosted demand for cholera vaccines in both public health and travel health settings. Oral vaccines are now preferred over injections due to ease of administration. The growing uptake of low-cost oral cholera vaccines through national immunization programs is expected to significantly reduce disease incidence.

Zambia Cholera Vaccines Market is estimated to be valued at US$ 1.47 million in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Zambia cholera vaccines market are Biovac Inc., Valneva SE., EMERGENT, Astellas Pharma Inc, Sanofi, EUBIOLOGICS CO., LTD,Johnson & Johnson Services Inc., Celldex Therapeutics. The rising incidence of cholera cases in the country is driving the demand for cholera vaccines. For instance, over 4,000 cases were recorded in 2021. Growing awareness among public and private healthcare providers about the benefits of cholera immunization is also boosting the market. Technological advancements such as development of new-generation oral vaccines with improved efficacy, safety and shelf-life have augmented their adoption.

Market trends:

Growing focus on preventive healthcare: Healthcare experts and government agencies in Zambia Cholera Vaccines Market Growth are promoting the increased use of preventive vaccines to curb public health issues like cholera in a cost-effective manner. This is positively impacting the sales prospects of cholera vaccines.

Rising focus on traveler's health: With increasing tourism and business activities, there is higher focus on immunization of international travelers coming to and from Zambia. This is driving demand for cholera vaccines.

Market Opportunities:

Expansion of national immunization programs: Significant market potential exists for vaccines makers by expanding the reach of government-led oral cholera vaccination programs in high-risk areas.

Increasing production of low-cost vaccines: There is scope for manufacturers to further lower vaccine prices by ramping up production volumes, which will maximize accessibility in resource-poor settings.

Impact of COVID-19 on Zambia Cholera Vaccines Market Growth

The COVID-19 pandemic has significantly impacted the growth of Zambia cholera vaccines market. During the initial phase of the pandemic, both vaccine supply and demand were disrupted due to nationwide lockdowns and movement restrictions imposed by the government to curb the spread of the virus. Production facilities had to temporarily halt operations while distribution channels were also disrupted. This led to shortage of vaccine supplies at a time when demand increased due to risk of COVID-19 infection exacerbating cholera symptoms.

However, post lockdowns, the Zambia cholera vaccines market witnessed increased focus and investments towards boosting production capacities to meet the demand during the pandemic. Government initiatives to provide vaccination drives and special provisions for at-risk communities helped regain momentum. The outbreak highlighted the need for improved public health infrastructure and vaccine access. It also raised awareness about the disease, driving demand. Manufacturers are now focusing on strengthening supply chains, identifying alternative sources and developing efficient distribution networks to ensure resilience against future disruptions.

The Western region accounts for the largest share of the Zambian cholera vaccines market in terms of value currently. With dominant urban centres such as Lusaka and presence of key manufacturing and healthcare facilities, vaccine demand is concentrated here. However, the Southern region is poised to be the fastest growing market due to increasing focus on rural vaccination drives to boost coverage in remote communities vulnerable to outbreaks. Investments are being made to enhance cold chain infrastructure in this region.

The Eastern region currently presents significant growth opportunities for players in the Zambia cholera vaccines market. With a predominantly agrarian population and cultural practices increasing risk of contamination, outbreaks are more frequent here. However, access to medical facilities is limited. Partnerships with NGOs operating in the region can help improve penetration and awareness levels to drive higher vaccine uptake over the coming years. Focusing distribution and advocacy initiatives in the Eastern province will be crucial for future expansion.

Get more insights on Zambia Cholera Vaccines Market